N-cadherin is well established as a pro-invasive cadherin, for example during the epithelial to mesenchymal transition that precedes cancer metastasis, during which epithelial (E)-cadherin is transcriptionally downregulated and N-cadherin upregulated. The gene discussed is CDH2; the disease is cancer.